Cleared Special

K193391 - BeneVision Central Monitoring System (FDA 510(k) Clearance)

May 2020
Decision
167d
Days
Class 2
Risk

K193391 is an FDA 510(k) clearance for the BeneVision Central Monitoring System. This device is classified as a System, Network And Communication, Physiological Monitors (Class II - Special Controls, product code MSX).

Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on May 21, 2020, 167 days after receiving the submission on December 6, 2019.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300.

Submission Details

510(k) Number K193391 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2019
Decision Date May 21, 2020
Days to Decision 167 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MSX — System, Network And Communication, Physiological Monitors
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2300